Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Inhaled Nitric Oxide on Sublingual Microcirculation in Patients With Right Ventricular Dysfunction After Cardiac Surgery
NCT07918976Phase 2Completed
- Sponsor
- Southeast University
- Start
- Oct 2024
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nitric oxide in Right ventricular dysfunction (RVD) and pulmonary hypertension (PH), sponsored by Southeast University. Primary endpoint: Perfused vessel density at 2 hours. Started Oct 2024; status: completed.
02
Drugs
nitric oxide
03
Conditions
Right ventricular dysfunction (RVD)pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07918976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07918976.